In an effort to better understand the cellular responses to COVID-19, the digital biology company Recursion has publicly released the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules on SARS-CoV-2- infected human cells. The images and data were acquired using the ImageXpress Micro Confocal High-Content Imaging System from Molecular Devices, LLC., a leading provider of high-performance bioanalytical measurement solutions.
Named RxRx19, the dataset from Recursion is an important contribution to a growing body of scientific data in the fight against COVID-19. The images and datasets are available and free online, giving researchers open access to both the images and the corresponding deep learning embeddings to analyze or apply to their own experimentation hypothesis.
Social distancing has us implementing new, effective ways to continue serving scientists so that their experiments and discoveries carry on – uninterrupted.
Our sales, training, and technical support teams are on the virtual frontlines with our customers, conducting remote product demonstrations, webinars and more for the innovative solutions Molecular Devices offers.
And because time is of the essence, global express processing and shipping is now available for many of our bioanalytical systems.
We understand this is a challenging time for our customers who have accelerated their efforts to combat COVID-19. Many have told us of the urgency to expedite turnaround time related to getting instruments into their labs.
To meet this need, we have implemented express processing and shipping on microplate readers, biopharma and cellular imaging systems. Applications include:
Together with our associates, we’re supporting organizations in the fight against COVID-19.
Here are some of the ways we’ve given back:
As a Danaher Corporation OpCo, we are also participating in the company’s giving program. Following Danaher’s $1 million USD donation spread evenly across four select non-profits focused on COVID-19 relief efforts, Danaher is matching our associates’ monetary donations 2:1 (up to an additional $1 million USD total) to these same organizations:
We remain grateful for those on the front lines of this pandemic and for the opportunity to support their efforts. We are all in this together.